📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

A novel antibody combination to identify KIR2DS2high natural killer cells in KIR2DL3/L2/S2 heterozygous donors. (2019)

First Author: Blunt M

Attributed to: Using MHC class I peptides to modulate NK cell activity, as a basis for immunotherapy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.33969

Publication URI: https://www.repository.cam.ac.uk/handle/1810/286657

Type: Journal Article/Review